-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-05-06
STVN:NYE- (USD)
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 21.25Change
-0.88 (-3.98)%Market Cap
USD 5.98BVolume
0.66MVerdict
Verdict
Values as of: 2025-05-06
COMMON STOCK | Medical Instruments & Supplies |
Last Closing
USD 21.25Change
-0.88 (-3.98)%Market Cap
USD 5.98BVolume
0.66MVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
BDX | Becton Dickinson and Company |
N/A |
USD 57.94B |
ALC | Alcon AG |
N/A |
USD 44.32B |
RMD | ResMed Inc |
N/A |
USD 31.43B |
BAX | Baxter International Inc |
N/A |
USD 14.28B |
SOLV | Solventum Corp. |
N/A |
USD 11.45B |
AVTR | Avantor Inc |
N/A |
USD 10.37B |
ATR | AptarGroup Inc |
N/A |
USD 9.51B |
TFX | Teleflex Incorporated |
N/A |
USD 5.79B |
BLCO | Bausch + Lomb Corp |
N/A |
USD 4.29B |
WRBY | Warby Parker Inc |
N/A |
USD 1.79B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
HCA:CA | Hamilton Canadian Bank Me.. | 25.98 % | 0.00 % |
N/A |
CAD 0.06B |
CIC:CA | CI Canadian Banks Covered.. | 16.79 % | 0.84 % |
N/A |
N/A |
ZEB:CA | BMO S&P/TSX Equal Weight .. | 14.96 % | 0.60 % |
N/A |
CAD 5.23B |
BNC:CA | Purpose Canadian Financia.. | 12.33 % | 0.68 % |
N/A |
N/A |
BANK:CA | Evolve Canadian Banks and.. | 11.55 % | 0.39 % |
N/A |
CAD 0.40B |
ZWB:CA | BMO Covered Call Canadian.. | 10.83 % | 0.71 % |
N/A |
CAD 2.92B |
CEW:CA | iShares Equal Weight Banc.. | 9.63 % | 0.60 % |
N/A |
CAD 0.23B |
RBNK:CA | RBC Canadian Bank Yield I.. | 8.06 % | 0.33 % |
N/A |
CAD 0.25B |
HEF:CA | 7.74 % | 0.83 % |
N/A |
N/A | |
HCB:CA | 6.95 % | 0.65 % |
N/A |
N/A | |
BFIN-U:CA | 5.72 % | 0.00 % |
N/A |
N/A | |
QXM:CA | First Asset Morningstar N.. | 5.42 % | 0.58 % |
N/A |
CAD 0.07B |
XDV:CA | iShares Canadian Select D.. | 5.22 % | 0.55 % |
N/A |
CAD 1.69B |
FIE:CA | iShares Canadian Financia.. | 4.96 % | 0.97 % |
N/A |
CAD 1.06B |
XFN:CA | iShares S&P/TSX Capped Fi.. | 4.06 % | 0.61 % |
N/A |
CAD 1.73B |
FBE:CA | 2.65 % | 0.83 % |
N/A |
N/A | |
MCLC:CA | Manulife Multifactor Cana.. | 0.00 % | 0.45 % |
N/A |
CAD 0.33B |
NDIV:CA | NBI Canadian Dividend Inc.. | 0.00 % | 0.00 % |
N/A |
CAD 0.02B |
DXIF:CA | Dynamic Active Internatio.. | 0.00 % | 0.00 % |
N/A |
CAD 6.86M |
Market Performance vs. Industry/Classification (Medical Instruments & Supplies) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | -2.48% | 68% | D+ | 49% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | -2.48% | 63% | D | 47% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -23.12% | 47% | F | 15% | F | ||
Dividend Return | 0.21% | 11% | F | 2% | F | ||
Total Return | -22.91% | 47% | F | 13% | F | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 8.48% | 84% | B | 65% | D | ||
Dividend Return | 8.51% | 84% | B | 59% | D- | ||
Total Return | 0.03% | 11% | F | 2% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 42.18% | 26% | F | 20% | F | ||
Risk Adjusted Return | 20.17% | 84% | B | 39% | F | ||
Market Capitalization | 5.98B | 53% | F | 81% | B- |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.